Pages that link to "Q61891161"
Jump to navigation
Jump to search
The following pages link to Premorbid antiplatelet use and ischemic stroke outcomes (Q61891161):
Displaying 13 items.
- Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke (Q34367350) (← links)
- Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis (Q36072444) (← links)
- Effect of low-dose aspirin on functional outcome from cerebral vascular events in women (Q36553503) (← links)
- Secondary stroke prevention: inside the vessels and beyond (Q37056590) (← links)
- Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome (Q37345715) (← links)
- Multifunctional actions of approved and candidate stroke drugs (Q37358654) (← links)
- Antidiabetic treatment, stroke severity and outcome (Q38205762) (← links)
- Antiplatelet Resumption after Antiplatelet-Related Intracerebral Hemorrhage: A Retrospective Hospital-Based Study (Q47314967) (← links)
- Biochemical aspirin resistance is associated with increased stroke severity and infarct volumes in ischemic stroke patients (Q47374731) (← links)
- (Q61893489) (redirect page) (← links)
- Prestroke Aspirin Use is Associated with Clinical Outcomes in Ischemic Stroke Patients with Atherothrombosis, Small Artery Disease, and Cardioembolic Stroke. (Q64970674) (← links)
- Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial? (Q81715687) (← links)
- Relapsed spontaneous spinal epidural hematoma associated with aspirin and clopidogrel (Q83586348) (← links)